Spastic Hemiparesis Clinical Trial
Official title:
Randomised Controlled Trial to Evaluate the Effect of a Self-rehabilitation Program in Addition to Usual Treatment for Spasticity (Repeated Botulinum Toxin Injections and Physiotherapy) on Impairment and Activity Limitation in Patients With Spastic Hemiparesis Following Stroke
The addition of a self-rehabilitation program to repeated Botulinum Toxin Injections (BTI) and usual physiotherapy should increase the proportion of patients who attain their Primary Treatment Goal (impairments and function) more than usual care (involving repeated Botulinum Toxin Injections and conventional physiotherapy), in post stroke out-patients with spasticity.
Stroke affects 150 000 persons in France each year. Most patients have activity limitations
because of the resulting motor deficit and spasticity. Autonomy in activities of daily living
is reduced.
The principal treatment for focal spasticity is currently intramuscular botulinum toxin
injection (BTI).
BTI is classically combined with only 2 to 3 sessions of out-patient physiotherapy per week.
This is mainly because of a lack of out-patient therapists. However, this amount of therapy
is insufficient and does not follow current literature which shows that the intensity of
physiotherapy affects the recovery of impairment and activity. This gap in our health system
could be filled by a self-rehabilitation program in addition to physiotherapy.
Recent studies have shown that self-rehabilitation following BTI could significantly improve
activity limitation (Roche et al, 2014 ; Sun et al 2010).
The addition of a self-rehabilitation program to BTI and usual out-patient physiotherapy
could thus increase the effects of BTI on impairment and activity limitation in patients with
spastic hemiparesis following stroke.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05436366 -
Soleus Loading Response During Walking
|
N/A | |
| Completed |
NCT05546190 -
A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)
|
||
| Completed |
NCT03549975 -
Hand Rehabilitation Using Botulinum Toxin and Functional Electrical Stimulation-pilot Study
|
Phase 4 | |
| Active, not recruiting |
NCT06001736 -
Utility of CC7 Transfer in Stroke Subtypes
|
N/A | |
| Completed |
NCT02969356 -
Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)
|
Phase 4 | |
| Recruiting |
NCT03402854 -
tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy
|
N/A |